Cargando…
Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients
BACKGROUND: There is an urgent need for the identification of new, clinically useful biomarkers of CRC to enhance diagnostic and prognostic capabilities. METHODS: We performed proteomic profiling on serum samples from paired pre- and post-operative CRC patients, colorectal polyps patients and health...
Autores principales: | Duan, Baojun, Bai, Jun, Qiu, Jian, Wang, Jianhua, Tong, Cong, Wang, Xiaofei, Miao, Jiyu, Li, Zongfang, Li, Wensheng, Yang, Juan, Huang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284455/ https://www.ncbi.nlm.nih.gov/pubmed/30361067 http://dx.doi.org/10.1016/j.ebiom.2018.10.036 |
Ejemplares similares
-
Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
por: Binda, Olivier
Publicado: (2019) -
Histone Lysine Methyltransferase SETD2 Regulates Coronary Vascular Development in Embryonic Mouse Hearts
por: Chen, Fengling, et al.
Publicado: (2021) -
Structure, activity and function of the lysine methyltransferase SETD5
por: Li, Mingyang, et al.
Publicado: (2023) -
Histone lysine methyltransferase Pr‐set7/SETD8 promotes neural stem cell reactivation
por: Huang, Jiawen, et al.
Publicado: (2021) -
Loss of histone methyltransferase SETD1B in oogenesis results in the redistribution of genomic histone 3 lysine 4 trimethylation
por: Hanna, Courtney W, et al.
Publicado: (2022)